Search research articles
Contact Us
Filters
Showing results (631-640 of 702) with videos related to
Page
of 71
Sort By:
The American Journal of Cardiology
|
May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation
Anjani Golive, Heidi T May, Tami L Bair, et al.
The Journal of General Virology
|
September 18, 2007
Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches
Sheng-Jiun Wu, Albert Schmidt, Eric J Beil, et al.
Journal of Cardiovascular Electrophysiology
|
August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia
Victoria Jacobs, Scott C Woller, Scott M Stevens, et al.
Plos One
|
July 11, 2018
Chronic debilitation in stranded loggerhead sea turtles (Caretta caretta) in the southeastern United States: Morphometrics and clinicopathological findings
Nicole I Stacy, Jennifer M Lynch, Michael D Arendt, et al.
American Heart Journal
|
June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarin
Kevin G Graves, Heidi T May, Victoria Jacobs, et al.
Trends in Immunology
|
December 18, 2016
Solving Immunology?
Yoram Vodovotz, Ashley Xia, Elizabeth L Read, et al.
Oral Oncology
|
May 29, 2020
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
D Day, A Prawira, A Spreafico, et al.
Journal of Cardiovascular Electrophysiology
|
January 16, 2015
Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes study
Arun Kanmanthareddy, Ajay Vallakati, Madhu Reddy Yeruva, et al.
Journal of Cardiovascular Electrophysiology
|
May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures
T Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE
|
September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks
T Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Page
of 71
Search research articles
Search
Showing results (631-640 of 702) with videos related to
Sort By:
Page
of 71
The American Journal of Cardiology
|
May 10, 2017
The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation
Anjani Golive, Heidi T May, Tami L Bair, et al.
The Journal of General Virology
|
September 18, 2007
Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches
Sheng-Jiun Wu, Albert Schmidt, Eric J Beil, et al.
Journal of Cardiovascular Electrophysiology
|
August 14, 2015
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long-Term Risk of Dementia
Victoria Jacobs, Scott C Woller, Scott M Stevens, et al.
Plos One
|
July 11, 2018
Chronic debilitation in stranded loggerhead sea turtles (Caretta caretta) in the southeastern United States: Morphometrics and clinicopathological findings
Nicole I Stacy, Jennifer M Lynch, Michael D Arendt, et al.
American Heart Journal
|
June 5, 2017
Atrial fibrillation incrementally increases dementia risk across all CHADS<sub>2</sub> and CHA<sub>2</sub>DS<sub>2</sub>VASc strata in patients receiving long-term warfarin
Kevin G Graves, Heidi T May, Victoria Jacobs, et al.
Trends in Immunology
|
December 18, 2016
Solving Immunology?
Yoram Vodovotz, Ashley Xia, Elizabeth L Read, et al.
Oral Oncology
|
May 29, 2020
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck
D Day, A Prawira, A Spreafico, et al.
Journal of Cardiovascular Electrophysiology
|
January 16, 2015
Pulmonary vein isolation for atrial fibrillation in the postpneumonectomy population: a feasibility, safety, and outcomes study
Arun Kanmanthareddy, Ajay Vallakati, Madhu Reddy Yeruva, et al.
Journal of Cardiovascular Electrophysiology
|
May 29, 2009
Warfarin is not needed in low-risk patients following atrial fibrillation ablation procedures
T Jared Bunch, Brian G Crandall, J Peter Weiss, et al.
Pacing and Clinical Electrophysiology : PACE
|
September 8, 2011
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks
T Jared Bunch, Srijoy Mahapatra, David Murdock, et al.
Page
of 71